Influence of overall treatment time and radiobiological parameters on biologically effective doses in cervical cancer patients treated with radiation therapy alone

Acta Oncologica

Volumn 43, Issue 7, 2004, Pages 657-666

  Gasinska, Anna ^a,c   Fowler, Jack F ^b   Lind, Bengt K ^c   Urbanski, Krzysztof ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE;

ADULT; AGED; ANEUPLOIDY; ARTICLE; BRACHYTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL KILLING; FEMALE; HUMAN; LABELING INDEX; MAJOR CLINICAL STUDY; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; RADIOSENSITIVITY; SURVIVAL TIME; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HEMOGLOBINS; HUMANS; MIDDLE AGED; MITOTIC INDEX; PLOIDIES; PROPORTIONAL HAZARDS MODELS; RADIATION TOLERANCE; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS; TIME FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 9444235151     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860410018511     Document Type: Article

References (38)

1. Denekamp J. Changes in the rate of repopulation during multifraction irradiation of mouse skin. Br J Radiol 1973; 46: 381-7.
2. Maciejewski B, Preuss-Bayer G, Trott KR. The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx. Int J Radiat Oncol Biol Phys 1983; 9: 321-8.
3. Withers HR, Taylor JMG, Maciejewski B. The hazard of the accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988; 27: 131-46.
4. Fowler JF. Potential for increasing the differential response between tumors and normal tissues: can proliferation rate be used? Int J Radiat Oncol Biol Phys 1986; 12: 641-5.
5. Ferrigno R, Ribeiro dos Santos Novaes PE, Pellizzon ACA, et al. High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications. Int J Radiat Oncol Biol Phys 2001; 50: 1123-35.
6. Fyles A, Keane TJ, Barton M, Simm J. The effect of treatment duration in local control of cervix cancer. Radiother Oncol 1992; 25: 273-9.
7. Girinsky T, Rey A, Roche B, et al. Overall treatment time in advanced cervical carcinoma: a critical parameter in treatment outcome. Int J Radiat Oncol Biol Phys 1993; 27: 1051-6.
8. Petereit DG, Sarkaria JN, Chappell R, et al. The adverse effect of treatment prolongation in cervical carcinoma. Int J Radiat Oncol Biol Phys 1995; 32: 1301-7.
9. Roberts SA, Hendry JH. The delay before onset of accelerated tumour cell repopulation during radiotherapy; a direct maximum-likelihood analysis of a collection of worldwide tumour-control data. Radiat Oncol 1993; 29: 69-74.
10. Erridge SC, Kerr GR, Downing D, Duncan W, Price A. The effect of overall treatment time on the survival and toxicity of radical radiotherapy for cervical carcinoma. Radiother Oncol 2002; 63: 59-66.
11. Withers HR. The four R's of radiotherapy. In: Lett JT, Adler H, eds. Advances in radiation biology. 5th ed. New York: Academic Press, 1975. p. 241-7.
12. Steel GG. Growth kinetics of tumours. Oxford: Clarendon Press; 1977.
13. Fowler JF, Lindstrom MJ. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 1992; 23: 457-67.
14. Parsons JT, Mendenhall WM, Stringer SP, Cassisi NJ, Millon RR. An analysis of factors influencing the outcome of post-operative irradiation for squamous cell carcinoma of the oral cavity. Int J Radiat Oncol Biol Phys 1997; 39: 137-48.
15. Urbanski K, Gasinska A, Pudelek J, Fowler JF, Lind B. Brahme A. Biologically effective doses in radiotherapy of cervical carcinoma. Neoplasma; 2004; 51: 228-38.
16. Gasinska A, Urbanski K, Jakubowicz K, Klimek M, Biesaga B, Wilson GD. Tumour cell kinetics as a prognostic factor in squamous cell carcinoma of the cervix treated with radiotherapy. Radiother Oncol 1999; 50: 77-84.
17. Wilson GD. Limitations of the bromodeoxyuridine technique for measurement of tumour proliferation. Medical Radiology. Current Topics in Clinical Radiobiology of Tumours. Berlin: Springer, 1993.
18. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989; 62: 679-94.
19. Dale RG, Jones B. The clinical radiobiology of brachytherapy. Brit J Radiol 1998; 71: 465-83.
20. Barendsen GW. Dose fractionation, dose rate and isoeffect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys 1982; 8: 1981-97.
21. Fowler JF. Dose reduction factors when increasing dose rate in LDR or MDR brachytherapy of carcinoma of the cervix. Radiother Oncol 1997; 45: 49-54.
22. Kaplan EL, Meier P. Non-parametric estimation for incomplete observations. J Am Stat Assoc 1956; 53: 457-81.
23. Cox DR. Regression models and life tables. J R Stat Soc 1972; 34: 187-220.
24. Gasinska A, Urbanski K, Adamczyk A, Pudelek J, Lind BK, Brahme A. High intratumour microvessel density and high hemoglobin level are associated with high survival in carcinoma of the uterine cervix. Acta Oncol 2002; 41: 437-43.
25. West CML. Invited review: Intrinsic radiosensitivity as a predictor of patient response to radiotherapy. Br J Radiol 1995; 68: 827-37.
26. Fowler JF. Lindstrom MJ. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 1992; 23: 457-67.
27. Tan LT, Jones B, Green JA, Kingston RE, Clark PI. Treatment of carcinomas of the uterine cervix which remain bulky after external beam radiotherapy: a pilot study using integrated cytotoxic chemotherapy prior to brachytherapy. Br J Radiol 1996; 69: 165-71.
28. Fowler JF. Rapid repopulation in radiotherapy: a debate on mechanism: the phantom of tumour treatment-continually rapid proliferation unmasked. Radiother Oncol 1991; 22: 156-8.
29. Eifel PJ, Thames HD. Has the influence of treatment duration on local control of carcinoma of the cervix been defined? Int J Radiat Oncol Biol Phys 1995; 32: 1527-9.
30. Keane T, Fyles A, O'Sullivan B, Barton M, Maki E, Simm J. The effect of treatment duration on local control of squamous carcinoma of the tonsil and carcinoma of the cervix. Sem Radiat Oncol 1992; 2: 26-8.
31. Lanciano RM, Pajak TF, Martz K, Hanks GE. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a patterns of care study. Int J Radiat Oncol Biol Phys 1993; 25: 391-7.
32. Ferez CA, Grigsby PW, Castro-Vita H, Lockett MA. Carcinoma of the uterine cervix. I: Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. Int J Radiat Oncol Biol Phys 1995; 32: 1275-88
33. Scalliet P, Gerbaulet A, Dubray R. HDR versus LDR gynecological brachytherapy revisited. Radiother Oncol 1993; 28: 118-26.
34. Skladowski K, Law MMG, Maciejewski B, Steel GG. Planned and unplanned gaps in radiotherapy: the importance of gap position and gap duration. Radiother Oncol 1994; 30: 109-20.
35. Tsang RW, Wong CS, Fyles AW, et al. M. Tumor proliferation and apoptosis in human uterine cervix carcinoma, II: Correlations with clinical outcome. Radiother Oncol 1999; 50: 93-101.
36. Wilson GD. A new look at proliferation. Acta Oncol 2001; 40: 989-94.
37. Begg AC, Haustermans K, Hart AAM, et al. The value of pretreatment cell kinetics parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis. Radiother Oncol 1999; 50: 13-23.
38. Chappell R, Fowler JF. How to efficiently model Tpot and why we should care. Int J Radiat Oncol Biol Phys 2002; 54 (Suppl 2): 54.